DANIEL LYNCH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL LYNCH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL LYNCH. DANIEL LYNCH is an Acting Chief Executive Officer in IMCLONE SYSTEMS INC ($IMCLE) and an Chief Executive Officer in IMCLONE SYSTEMS INC ($IMCLE) and a in bluebird bio, Inc. ($BLUE) and a Director in bluebird bio, Inc. ($BLUE) and a Director in BIND Therapeutics, Inc ($BIND) and a Director in Eleven Biotherapeutics, Inc. ($EBIO) and a Director in Blueprint Medicines Corp ($BPMC) and a Director in Translate Bio, Inc. ($TBIO) and a Director in Surface Oncology, Inc. ($SURF) and a Director in SpringWorks Therapeutics, Inc. ($SWTX).
Companies in which DANIEL LYNCH is an Insider
bluebird bio, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL LYNCH:
Holdings: 5,859 shares
Current Value: $431,808
Latest Transaction: Jun 22 2020
$BLUE Market Capitalization: $2.75B
$BLUE Previous Close: $73.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Blueprint Medicines Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL LYNCH: Director
Holdings: 127,904 shares
Current Value: $4,584,079
Latest Transaction: Jun 26 2020
$BPMC Market Capitalization: $979.55M
$BPMC Previous Close: $35.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DNIB UNWIND, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL LYNCH: Director
Holdings: 20,000 shares
Latest Transaction: Aug 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMCLONE SYSTEMS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL LYNCH: Acting Chief Executive Officer
Holdings: 0 shares
Latest Transaction: Dec 22 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sesen Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL LYNCH: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 21 2019
$SESN Market Capitalization: $34.48M
$SESN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SpringWorks Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL LYNCH: Director
Holdings: 0 shares
Latest Transaction: May 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Surface Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL LYNCH: Director
Holdings: 0 shares
Latest Transaction: Jun 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Translate Bio, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL LYNCH: Director
Holdings: 0 shares
Latest Transaction: Jun 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DANIEL LYNCH
Sentiment: All, BLUE, BPMC, BIND, IMCLE, SESN, SWTX, SURF, TBIO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26 2020 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Grant | A | 0.00 | 2,250 | 0 | 127,904 | 125.7 K to 127.9 K (+1.79 %) |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Buy | M | 0.00 | 1,312 | 0 | 125,654 | 124.3 K to 125.7 K (+1.06 %) |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Option Exercise | A | 64.09 | 4,200 | 269,178 | 4,200 | ||
| Jun 22 2020 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Grant | A | 0.00 | 2,100 | 0 | 7,959 | 5.9 K to 8 K (+35.84 %) | |
| Jun 22 2020 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Grant | A | 0.00 | 259 | 0 | 5,859 | 5.6 K to 5.9 K (+4.63 %) |